International Journal of Nephrology · Published 2024-01-01 · DOI 10.1155/ijne/1555811
Conclusion: The study’s findings revealed a significant increase in miR-210-3p expression in sepsis patients with AKI, indicating its potential as a promising biomarker for determining AKI. This discovery demonstrates that the diagnostic performance of miR-210-3p surpasses that of miR-10a-5p, providing a more accurate biomarker for diagnosing AKI in sepsis patients.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →